NDC 51655-720

Cephalexin

Cephalexin

Cephalexin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is Cephalexin.

Product ID51655-720_7307d314-f1cd-74f1-e053-2a91aa0a01b2
NDC51655-720
Product TypeHuman Prescription Drug
Proprietary NameCephalexin
Generic NameCephalexin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2015-10-09
Marketing CategoryANDA / ANDA
Application NumberANDA065248
Labeler NameNorthwind Pharmaceuticals
Substance NameCEPHALEXIN
Active Ingredient Strength500 mg/1
Pharm ClassesCephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51655-720-52

30 CAPSULE in 1 BOTTLE (51655-720-52)
Marketing Start Date2015-10-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51655-720-51 [51655072051]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA065248
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-09
Inactivation Date2020-01-31

NDC 51655-720-29 [51655072029]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA065248
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-11-15
Inactivation Date2020-01-31

NDC 51655-720-52 [51655072052]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA065248
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-10-28
Inactivation Date2020-01-31

NDC 51655-720-20 [51655072020]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA065248
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-10-09
Inactivation Date2020-01-31

NDC 51655-720-53 [51655072053]

Cephalexin CAPSULE
Marketing CategoryANDA
Application NumberANDA065248
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-08
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
CEPHALEXIN500 mg/1

OpenFDA Data

SPL SET ID:558b1937-a29b-32b1-e054-00144ff8d46c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309114
  • Pharmacological Class

    • Cephalosporin Antibacterial [EPC]
    • Cephalosporins [CS]

    NDC Crossover Matching brand name "Cephalexin" or generic name "Cephalexin"

    NDCBrand NameGeneric Name
    0093-2238CephalexinCephalexin
    0093-2240CephalexinCephalexin
    0093-3145CephalexinCephalexin
    0093-3147CephalexinCephalexin
    0093-4175CephalexinCephalexin
    0093-4177CephalexinCephalexin
    0143-9769CephalexinCephalexin
    0143-9770CephalexinCephalexin
    0143-9897CephalexinCephalexin
    0143-9898CephalexinCephalexin
    67877-220CephalexinCephalexin
    67877-254CephalexinCephalexin
    67877-255CephalexinCephalexin
    67877-219CephalexinCephalexin
    68071-1585CephalexinCephalexin
    68071-4177CephalexinCephalexin
    68071-3186CephalexinCephalexin
    68071-4355CephalexinCephalexin
    68071-4342CephalexinCephalexin
    68071-4465CephalexinCephalexin
    68071-4233CephalexinCephalexin
    68071-4406CephalexinCephalexin
    68071-4429CephalexinCephalexin
    68071-4587CephalexinCephalexin
    68071-4516CephalexinCephalexin
    68071-4434CephalexinCephalexin
    0440-1243CephalexinCephalexin
    0440-7244CephalexinCephalexin
    68180-124cephalexincephalexin
    68180-441cephalexincephalexin
    68180-121CephalexinCephalexin
    68180-123cephalexincephalexin
    68180-440cephalexincephalexin
    68180-122CephalexinCephalexin
    68788-8986CephalexinCephalexin
    68788-9404CephalexinCephalexin
    68788-7271CephalexinCephalexin
    68788-9713CephalexinCephalexin
    68788-9326CephalexinCephalexin
    68788-9951cephalexincephalexin
    68788-8994CephalexinCephalexin
    68788-7391CephalexinCephalexin
    68788-9539CephalexinCephalexin
    68788-9950cephalexincephalexin
    68788-9956cephalexincephalexin
    68788-9538CephalexinCephalexin
    68788-9752cephalexincephalexin
    68788-9957cephalexincephalexin
    69543-102CephalexinCephalexin
    69778-930CephalexinCephalexin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.